Arcutis Biotherapeutics, Inc.
ARQT
$26.23
$0.311.20%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 15.01M | -11.30M | 17.40M | 7.41M | -15.89M |
| Total Depreciation and Amortization | 563.00K | 562.00K | 563.00K | 562.00K | 563.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.30M | 11.18M | 10.55M | 10.22M | 10.52M |
| Change in Net Operating Assets | -16.23M | 1.79M | -2.33M | -19.94M | 5.13M |
| Cash from Operations | 12.64M | 2.24M | 26.19M | -1.75M | 324.00K |
| Capital Expenditure | -158.00K | -- | 0.00 | 0.00 | -78.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -15.07M | -11.33M | -34.18M | -25.25M | 17.50M |
| Cash from Investing | -15.22M | -11.33M | -34.18M | -25.25M | 17.42M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.99M | 1.07M | 3.72M | 1.48M | 1.38M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.00M | -- | -- | -- | -- |
| Cash from Financing | 1.99M | 1.07M | 3.72M | 1.48M | 1.38M |
| Foreign Exchange rate Adjustments | -46.00K | -119.00K | 59.00K | -95.00K | 200.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -641.00K | -8.15M | -4.21M | -25.62M | 19.33M |